Clinical Laboratory Standards Institute (CLSI) Guidelines for Severe Combined Immunodeficiency (SCID)
Date:
September 20, 2017
Clinical Laboratory Standards Institute (CLSI) has developed guidelines for Severe Combined Immunodeficiency (SCID): Newborn Blood Spot Screening for Severe Combined Immunodeficiency by Measurement of T-cell Receptor Excision Circles; Approved Guideline. This document addresses laboratory issues as well as short-term follow-up for SCID.
Additional resources from CLSI can be found here.